menu
    • menu

    Company profile for Vir Biotechnology

    NEW Drugs in Dev: 14
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Vir is a science-driven company guided by medical need. Vir integrates diverse innovations in science, technology, and medicine to transform the care of people with serious infectious diseases. Vir is taking a multi-program, multi-platform approach to applying these breakthroughs, including the development of treatments that induce protective and therapeutic immune responses. Vir’s scale and scope, together with leading scie...
    Vir is a science-driven company guided by medical need. Vir integrates diverse innovations in science, technology, and medicine to transform the care of people with serious infectious diseases. Vir is taking a multi-program, multi-platform approach to applying these breakthroughs, including the development of treatments that induce protective and therapeutic immune responses. Vir’s scale and scope, together with leading scientific and management expertise, allow it to perform significant internal R&D, in-license or acquire innovative technology platforms and assets, and fund targeted academic research

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Vir BiotechnologyUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    499 Illinois Suite 500 San Francisco, CA 94158
    Telephone
    Telephone
    415-906-4324
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.vir.bio/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vir Biotechnology Presents Phase 2 SOLSTICE Week 96 Data at EASL
    Vir Biotechnology Presents Phase 2 SOLSTICE Week 96 Data at EASL

    18 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-18/vir-biotechnology-to-present-complete-week-96-data-from-phase-2-solstice-clinical-trial-in-hepatitis

    PHARMIWEB
    18 May 2026
    Share Share
    Vir Bio Updates On Corporate Progress And Q1 2026 Financials
    Vir Bio Updates On Corporate Progress And Q1 2026 Financials

    06 May 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-05-06/vir-biotechnology-provides-corporate-update-and-reports-first-quarter-2026-financial-results

    PHARMIWEB
    06 May 2026
    Share Share
    Vir Bio To Host Q1 2026 Financial Results Call
    Vir Bio To Host Q1 2026 Financial Results Call

    23 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-23/vir-biotechnology-to-host-conference-call-for-first-quarter-2026-financial-results

    PHARMIWEB
    23 Apr 2026
    Share Share
    Vir Bio, Astellas Close Global Partnership For Prostate Cancer
    Vir Bio, Astellas Close Global Partnership For Prostate Cancer

    16 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-16/vir-biotechnology-announces-closing-of-global-strategic-collaboration-with-astellas-for-the-treatmen

    PHARMIWEB
    16 Apr 2026
    Share Share
    Vir Doses First Patient with PSMA-Targeted VIR-5500 in mPC Trial
    Vir Doses First Patient with PSMA-Targeted VIR-5500 in mPC Trial

    13 Apr 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-04-13/vir-biotechnology-announces-first-patient-dosed-in-phase-1-dose-expansion-cohorts-evaluating-psma-ta

    PHARMIWEB
    13 Apr 2026
    Share Share
    Vir Biotech Announces Pricing of Public Offering of Common Stock
    Vir Biotech Announces Pricing of Public Offering of Common Stock

    26 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-26/vir-biotechnology-announces-pricing-of-public-offering-of-common-stock

    PHARMIWEB
    26 Feb 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search